SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?


To: Thure Meyer who wrote (1264)5/24/1999 11:03:00 PM
From: CASINO1  Respond to of 1837
 
There was a piece on the news last week, about women out numbering men on the net. I think CENESTIN will get a lot of chat when it hits the market. Plus they talk more freely about health subjects than men.



To: Thure Meyer who wrote (1264)5/25/1999 7:36:00 AM
From: vestor  Respond to of 1837
 
Great post ! I love substance..... I think your work effort here will be greatly appreciated.... and rewarding.. Any thoughts or info regarding the presentations some posters are saying that DRMD is supposedly making this week.... Before getting excited, I'd like to confirm....



To: Thure Meyer who wrote (1264)5/26/1999 7:12:00 PM
From: vestor  Read Replies (2) | Respond to of 1837
 
DRMD - Gets approval to manufacture Verapamil Hydochloride extended release tablets...... Perhaps a press release will be out tomorrow.... Anyone know what this drug is for and what financial impact this one has?